TNK2 and prostate carcinoma: TNK2, also known as ACK1 (activated Cdc42-associated kinase), is a non-receptor tyrosine kinase which has been shown to be frequently amplified or mutated in multiple human cancers including breast, esophageal, lung, ovarian, pancreatic and prostate cancer [12, 13].